Keywords
COVID-19
Anxiety
Depression
Patient Health Questionnaire
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To assess health-related quality of life (HRQoL), quality of life (QoL) and symptoms of anxiety and depression one year after hospital discharge in COVID-19 survivors. Methods: This is a quantitative, descriptive and exploratory study. The sample consisted of 41 patients admitted to a public hospital in the State of Ceará for the treatment of COVID-19 from March to December 2020. To assess QOL, the WHOQOL-bref instrument was applied; for SF-36 Item Short-Form Health Survey (SF-36) instrument and to investigate signs and symptoms of anxiety and depression the HADS. Data collection took place by telephone call one year after hospital discharge. Results: The study showed that female patients hospitalized due to COVID-19 faced more compromised QOL, HRQoL and symptoms of anxiety and depression up to one year after hospital discharge compared to males. Conclusion: This study showed that people who were hospitalized as a result of COVID-19 face impaired QOL, HRQoL and symptoms of anxiety and depression up to one year after hospital discharge, with women with greater impairment.
References
AKISKAL KK e AKISKAL HS. The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature. J Affect Disord, 2005; 85(1-2): 231-9.
ALMEIRDA-BRASIL CC, et al. Qualidade de vida e características associadas: Aplicação do WHOQOL-BREF no contexto da Atenção Primária à Saúde. Ciência e Saúde Coletiva, 2017; 22(5): 1705–1716.
BAI F, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin MicrobiolInfect, 2022; 28(4): 611.e9-611.e16.
BOTEGA NJ, et al. Validação da escala hospitalar de ansiedade e depressão (HAD) em pacientes epilépticos ambulatoriais. J Bras Psiq, 1998; 47: 285-289.
CARFÌ A, et al. Persistent symptoms in patients after acute COVID-19. Jama, 2020; 324(6): 603-605.
CARVALHO TM, et al. Índice de vulnerabilidade à COVID-19: uma aplicação para a cidade de Fortaleza (CE), Brasil. Engenharia Sanitaria e Ambiental, 2021; 26(4): 731–739.
CHAIX B, et al. Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations. General psychiatry, 2020; 33(6).
CICONELLI RM, et al. Tradução para a língua portuguesa e validação do questionáriogenérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol, 1999; 39: 143-50.
DIMITROVA BC, et al. Quality of life. London: BMJ Books, 2003. 133 pp. ISBN 0-7279-1544-4. European journal of public health, 2005; 15(6): 668-668.
FINE PG. Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med, 2011; 12(7): 996-1004.
FLECK M et al. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida" WHOQOL-bref". Revista de saúde pública, 2000; 34: 178-183.
FLOR LS, et al. Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021. Lancet, 2022; 399(10344): 2381-2397.
FRAMEWORK I. Conceptual. The MOS 36-item short-form health survey (SF-36). Med Care, 1992; 30, (6): 473-83.
HARAPAN BN e YOO HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol, 2021; 268(9): 3059-3071.
HARRIS PA, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform, 2019; 95: 103208.
HEESAKKERS H, et al. Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. JAMA, 2022; 327(6): 559-565.
HERRIDGE MS, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive care medicine, 2016; 42 (5): 725-738.
KHOJA O, et al. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID. J Pain Res, 2022; 17(15): 1729-1748.
KOOHI F, et al. Quality of Life among General Populations of Different Countries in the Past 10 Years, with a Focus on Human Development Index: A Systematic Review and Meta-analysis. Iran J Public Health, 2017; 46(1): 12-22.
NALBANDIAN A, et al. Post-acute COVID-19 syndrome. Nature medicine, 2021; 27(4): 601-615.
NEPOMUCENO E, et al. Comparação de instrumentos para avaliar fadiga em pacientes com insuficiência cardíaca. Revista Brasileira de Enfermagem, 2018; 71: 2404-2410.
PIEH C, et al. The effect of age, gender, income, work, and physical activity on mental health during coronavirus disease (COVID-19) lockdown in Austria. J Psychosom Res. 2020; 136: 110186.
PIQUERO AR, et al. Domestic violence during the COVID-19 pandemic-Evidence from a systematic review and meta-analysis. Journal of criminal justice, 2021; 74: 101806.
PODESTÁ MHMC, et al. Qualidade de vida dos usuários da Atenção Primária à Saúde: perfil e fatores que interferem. RUVRD 2013; 11(2): 316-326.
REIGADA CL de L e SMIDERLE C de ASL. Atenção à saúde da mulher durante a pandemia COVID-19: orientações para o trabalho na APS. Rev Bras Med Fam Comunidade, 2021; 16(43): 2535.
RODRIGUES MVC. Qualidade de vida no trabalho: evolução e análise num nível gerencial. 8ª ed. Petrópolis: Vozes, 2001.
RUDROFF T, et al. Post-COVID-19 Fatigue: Potential Contributing Factors. Brain Sci, 2020; 10(12): 1012.
SHAH W, et al. UK guidelines for managing long-term effects of COVID-19. Lancet (London, England), 2021; 397(10286): 1706.
SIVAN M, et al. Post‐COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross‐sectional evaluation from a community COVID rehabilitation service. Journal of medical virology, 2022; 94(4): 1419-1427.
STIVAL MM, et al. Fatores associados à qualidade de vida de idosos que frequentam uma unidade de saúde do Distrito Federal. Revista Brasileira de Geriatria e Gerontologia, 2014; 17(2): 395–405.
WANG J, et al. Gender difference in neural response to psychological stress. Soc Cogn Affect Neurosci, 2007; 2(3): 227-39.
WARE JEJ e SHERBOURNE CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical care, 1992; 30(6): 473–483.
WOMEN UN e SNYDER D. COVID-19 and the care economy: Immediate action and structural transformation for a gender-responsive recovery. Policy Brief, 2020; 16(16).
XIE Y, et al. Risks of mental health outcomes in people with covid-19: cohort study. BMJ, 2022; 16(376): e068993.
ZIEGLER CGK, et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell, 2020; 181(5): 1016-1035.e19.
ZIGMONDI A S e SNALTH RP. The Hospital Anxiety and Depression Scale. Acta psychiatr. scand., 2014; 64(5): 361-370.